AEON Biopharma, Inc.
AEON
$0.77
-$0.05-5.52%
AMEX
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 2.33M | 3.26M | 3.13M | 2.63M | 3.04M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 2.93M | 4.32M | 3.95M | 5.67M | 4.02M |
| Operating Income | -2.93M | -4.32M | -3.95M | -5.67M | -4.02M |
| Income Before Tax | -4.54M | -6.64M | 9.10M | 2.08M | -6.17M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -4.54M | -6.64M | 9.10M | 2.08M | -6.17M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -4.54M | -6.64M | 9.10M | 2.08M | -6.17M |
| EBIT | -2.93M | -4.32M | -3.95M | -5.67M | -4.02M |
| EBITDA | -2.91M | -4.30M | -3.93M | -5.64M | -3.99M |
| EPS Basic | -0.39 | -0.60 | 2.28 | 3.76 | -11.24 |
| Normalized Basic EPS | -0.17 | -0.27 | 1.14 | -5.35 | -4.89 |
| EPS Diluted | -0.39 | -0.60 | 2.28 | 3.47 | -11.24 |
| Normalized Diluted EPS | -0.17 | -0.27 | 1.14 | -5.34 | -4.89 |
| Average Basic Shares Outstanding | 11.63M | 11.09M | 3.98M | 554.30K | 549.20K |
| Average Diluted Shares Outstanding | 11.63M | 11.09M | 3.98M | 555.30K | 549.20K |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |